Tamoxifen Tablets

BRITISH DRAGON TAMOXIFEN

Tamoxifen Tablets, manufactured by British Dragon, is a pharmaceutical formulation containing Tamoxifen Citrate as the active substance. Each tablet typically provides 20 mg of Tamoxifen Citrate. Tamoxifen is a selective estrogen receptor modulator (SERM) with anti-estrogenic properties.

DRUG COMPOSITION

Each tablet of Tamoxifen contains 20 mg of Tamoxifen Citrate.

PHARMACEUTICAL FORM

Tamoxifen is formulated in tablet form for oral administration.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antineoplastic and immunomodulating agents; ATC code: L02BA01.

PHARMACOLOGICAL PROPERTIES

Tamoxifen is a nonsteroidal anti-estrogen that competitively inhibits estrogen binding to its receptor. It is widely used in the treatment of estrogen receptor-positive breast cancer.

PROFILE

• Chemical name: Tamoxifen citrate
• Chemical formula: C32H37NO8
• Percentage of anabolic activity: N/A
• Percentage of androgenic activity: N/A
• Active half life: 5-7 days
• Recommended dosage: 20-40 mg per day
• Acne: Possible
• Bloating (water retention): Rare
• HBR: Low
• Hepatic toxicity: Possible, but rare
• Aromatization: No

THERAPEUTICAL INDICATIONS

Tamoxifen is indicated for the treatment of breast cancer, both in the adjuvant setting and for metastatic disease. It is also used to reduce the risk of breast cancer in high-risk individuals.

DOSES AND METHOD OF ADMINISTRATION

The dosage of Tamoxifen and the method of administration are individualized based on the patient's medical condition. It is typically taken orally, with or without food.

CYCLE/STACKING

Solo cycle:

• Tamoxifen is often used as a standalone therapy for breast cancer treatment, particularly in hormone receptor-positive cases.

Cutting cycle:

• Tamoxifen may be included in cutting cycles to manage estrogen-related side effects when using aromatizable anabolic steroids.

Bulking cycle:

• Tamoxifen can be used in bulking cycles to control estrogen levels, especially when incorporating compounds that may lead to aromatization.

POST CYCLE THERAPY

Tamoxifen is a cornerstone in post-cycle therapy (PCT) for individuals recovering from the use of anabolic steroids. Typical PCT doses and duration may vary.

SIDE EFFECTS

Common side effects include hot flashes, nausea, and vaginal discharge. Serious side effects are rare but may include increased risk of uterine cancer.

CONTRAINDICATIONS

Tamoxifen is contraindicated in individuals with a history of hypersensitivity to the drug. It should not be used in pregnant women or those with a history of blood clots.

OVERDOSE

In case of overdose, seek medical attention immediately.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Patients should be monitored for signs of endometrial cancer, thromboembolic events, and other potential side effects.

INTERACTIONS WITH OTHER DRUGS

Tamoxifen may interact with certain medications, and patients should inform healthcare providers of all medications being taken.

PRESENTATION, PACKAGING

20 mg per tablet, 50 tablets in sachet.

STORAGE

Store Tamoxifen in a cool, dry place, protected from light.

LEGAL STATUS

Tamoxifen is a prescription medication and is subject to legal regulations.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

British Dragon
Europe

EXTERNAL LINKS

• Tamoxifen Citrate Wiki, wikipedia.org
• Tamoxifen Uses, Dosage, Side Effects, drugs.com
• Tamoxifen CITRATE - Uses, Side Effects, and More, webmd.com.